The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice.
Choi J, Matoba N, Setoyama D, Watanabe D, Ohnishi Y, Yasui R, Kitai Y, Oomachi A, Kotobuki Y, Nishiya Y, Pieper MP, Imamura H, Yanagita M, Yamamoto M.
Choi J, et al. Among authors: nishiya y.
Commun Biol. 2023 Mar 17;6(1):278. doi: 10.1038/s42003-023-04663-y.
Commun Biol. 2023.
PMID: 36932133
Free PMC article.